From: Prevalence of metabolic syndrome in ankylosing spondylitis: a multi national meta-analysis study
Variable | Number of effect sizes | Prevalence | 95%CI | Tau2 | I2 | H2 | |
---|---|---|---|---|---|---|---|
Continent | Africa | 1 | 0.37 | 0.23–0.53 | 0.00 | --- | --- |
Asia | 5 | 0.08 | 0.05–0.13 | 0.02 | 95.51 | 22.26 | |
Europe | 15 | 0.16 | 0.11-21 | 0.05 | 82.95 | 5.87 | |
South America | 1 | 0.27 | 0.16–0.38 | 0.00 | --- | --- | |
AS definition | ASAS | 1 | 0.37 | 0.23–0.53 | 0.00 | --- | --- |
ICD-9-CM | 2 | 0.03 | 0.02–0.03 | 0.00 | 0.00 | 1.00 | |
Modified New York criteria | 18 | 0.16 | 0.12–0.22 | 0.06 | 85.75 | 7.02 | |
Mets criteria | CDS | 1 | 0.19 | 0.12–0.27 | 0.00 | --- | --- |
EGIR | 1 | 0.13 | 0.07–0.20 | 0.00 | --- | --- | |
Harmonized definition/JC | 2 | 0.13 | 0.04–0.25 | 0.04 | 84.05 | 6.27 | |
IDF/JC | 5 | 0.19 | 0.12–0.28 | 0.03 | 79.44 | 4.86 | |
Internationally Recognized Standards | 1 | 0.23 | 0.11–0.37 | 0.00 | --- | --- | |
NCEP-ATP III | 8 | 0.20 | 0.12–0.31 | 0.09 | 87.74 | 8.15 | |
WHO | 1 | 0.13 | 0.07–0.20 | 0.00 | --- | --- | |
Gender | Men | 5 | 0.26 | 0.21–0.32 | 0.00 | 28.58 | 1.40 |
Women | 6 | 0.23 | 0.09–0.40 | 0.11 | 73.98 | 3.84 | |
Quality score | 10 | 3 | 0.07 | 0.003-0.20 | 0.11 | 99.53 | 213.26 |
9 | 4 | 0.18 | 0.01–0.45 | 0.33 | 93.56 | 15.74 | |
8 | 13 | 0.16 | 0.12–0.21 | 0.03 | 79.93 | 4.98 | |
6 | 1 | 0.27 | 0.16–0.38 | 0.00 | --- | --- | |
4 | 1 | 0.13 | 0.08–0.20 | 0.00 | --- | --- | |
Age | 34-39.9 | 13 | 0.09 | 0.5 − 0.14 | 0.06 | 96.38 | 27.62 |
40-44.9 | 6 | 0.26 | 0.20–0.32 | 0.01 | 46.52 | 1.87 | |
Over 45 | 1 | 0.30 | 0.09–0.57 | 0.12 | 83.41 | 6.03 |